Rilotumumab, formerly designated AMG 102, is a monoclonal antibody mainly utilized as a useful research tool to probe the pathways driving abnormal expansion . Such therapeutic selectively targets https://deannatckz371863.mpeblog.com/75527062/rilotumumab-amg-102-a-research-method-for-examining-tumor-development